港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

恆瑞醫藥

55.150

+11.10025.20%

成交量：8,266.38萬

成交額：47.34億

市值：3,641.84億

市盈率：53.23

高：60.500

開：57.000

低：55.150

收：44.050

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

恆瑞醫藥

交易所：

SEHK

成立時間：

1970

員工人數：

20238

公司地址：

No. 38, Huanghe Road,Economic and Technological Development Zone,Lianyungang City,Jiangsu Province,China

官網：

http://www.hrs.com.cn

郵編：

222000

電話：

86 40 0828 3900

傳真：

- -

簡介：

公司創立於1970年,於2000年在上海證券交易所上市,是一家專註研發、生產及推廣高品質藥物的創新型國際化製藥企業,聚焦腫瘤、代謝和心血管疾病、免疫和呼吸系統疾病以及神經科學等領域進行新藥研發,是國內最具創新能力的製藥龍頭企業之一。公司的主要業務涉及藥品的研發、生產和銷售。主要產品:馬來酸吡咯替尼片、注射用卡瑞利珠單抗、瑞維魯胺片、海曲泊帕乙醇胺片、碘佛醇注射液、酒石酸布托啡諾注射液等。企業榮譽:“環保示範性企事業單位”及江蘇省“綠色發展領軍企業”,2023年獲得連雲港經濟技術開發區企業“環境保護質量獎”、榮獲中國醫藥質量管理協會頒發的“首批無菌藥品質量保障企業”榮譽稱號、江蘇省醫藥質量管理協會頒發的“江蘇省醫藥行業優秀質量管理企業”榮譽稱號;公司“雛鷹QC小組”、“遠志QC小組”被評為江蘇省醫藥行業質量管理(QC)發表交流優秀小組、江蘇省“綠色發展領軍企業”等。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01276/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恆瑞醫藥","latestPrice":55.15,"timestamp":1747987708026,"preClose":44.05,"halted":0,"volume":82663811,"delay":0,"floatShares":224519800,"shares":6603522074,"eps":1.036,"marketStatus":"未開盤","change":11.1,"latestTime":"05-23 16:08:28","open":57,"high":60.5,"low":55.15,"amount":4733500812,"amplitude":0.121453,"askPrice":55.5,"askSize":2200,"bidPrice":55.15,"bidSize":14200,"shortable":0,"etf":0,"ttmEps":1.036205539,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748223000000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":44.05,"dividendRate":0.003941,"openAndCloseTimeList":[[1747963800000,1747972800000],[1747976400000,1747987200000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恆瑞醫藥","latestPrice":54.5,"timestamp":1747983600000,"preClose":55.4,"halted":0,"volume":54184000,"delay":0,"premium":"-7.34"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":224519800,"roa":"8.99%","roe":"15.22%","lyrEps":1.036,"shares":6603522074,"dividePrice":0.218423,"high":60.5,"amplitude":0.121453,"preClose":44.05,"low":55.15,"week52Low":55.15,"pbRate":"7.10","psRate":"11.42","week52High":60.5,"institutionHeld":0,"latestPrice":55.15,"committee":0.731707,"eps":1.036,"divideRate":0.003961,"volume":82663811,"delay":0,"ttmEps":1.036205539,"open":57,"prevYearClose":44.05,"prevWeekClose":44.05,"prevMonthClose":44.05,"prevQuarterClose":44.05,"fiveDayClose":44.05,"twentyDayClose":44.05,"sixtyDayClose":44.05},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6153489,"yearFounded":1970,"employeeNum":20238,"address":"No. 38, Huanghe Road,Economic and Technological Development Zone,Lianyungang City,Jiangsu Province,China","zipCode":"222000","officePhone":"86 40 0828 3900"},"stockCompanyDetail":{"websiteUrl":"http://www.hrs.com.cn","stockEarnings":[{"period":"1week","weight":0.252},{"period":"ytd","weight":0.252}],"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0693},{"period":"3month","weight":0.0053},{"period":"6month","weight":0.2273},{"period":"1year","weight":0.2508},{"period":"ytd","weight":0.1765}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"公司創立於1970年,於2000年在上海證券交易所上市,是一家專註研發、生產及推廣高品質藥物的創新型國際化製藥企業,聚焦腫瘤、代謝和心血管疾病、免疫和呼吸系統疾病以及神經科學等領域進行新藥研發,是國內最具創新能力的製藥龍頭企業之一。公司的主要業務涉及藥品的研發、生產和銷售。主要產品:馬來酸吡咯替尼片、注射用卡瑞利珠單抗、瑞維魯胺片、海曲泊帕乙醇胺片、碘佛醇注射液、酒石酸布托啡諾注射液等。企業榮譽:“環保示範性企事業單位”及江蘇省“綠色發展領軍企業”,2023年獲得連雲港經濟技術開發區企業“環境保護質量獎”、榮獲中國醫藥質量管理協會頒發的“首批無菌藥品質量保障企業”榮譽稱號、江蘇省醫藥質量管理協會頒發的“江蘇省醫藥行業優秀質量管理企業”榮譽稱號;公司“雛鷹QC小組”、“遠志QC小組”被評為江蘇省醫藥行業質量管理(QC)發表交流優秀小組、江蘇省“綠色發展領軍企業”等。","exchange":"SEHK","name":"恆瑞醫藥","nameEN":"HENGRUI PHARMA"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3182,"buy":0.4091,"hold":0.2273,"sell":0.0455,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4091,"analysts":22,"updateTime":1743523200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2025-05-23","current":52.570963,"percent":0,"low":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"high":53.632028,"avg":53.101495,"sd":0.530532,"marketCap":390693388207.53},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53}],"updateTime":1748171518645}}}